We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · April 06, 2017

Extended Treatment With Rivaroxaban Bests Aspirin for Recurrent VTE Prevention

The New England Journal of Medicine

 

Additional Info

The New England Journal of Medicine
Rivaroxaban or Aspirin for Extended Treatment of Venous Thromboembolism
N. Engl. J. Med 2017 Mar 30;376(13)1211-1222, JI Weitz, AW Lensing, MH Prins, R Bauersachs, J Beyer-Westendorf, H Bounameaux, TA Brighton, AT Cohen, BL Davidson, H Decousus, MC Freitas, G Holberg, AK Kakkar, L Haskell, B van Bellen, AF Pap, SD Berkowitz, P Verhamme, PS Wells, P Prandoni

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading